We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

ZETA:NYSEZeta Global Holdings Corp. Analysis

Data as of 2026-05-12 - not real-time

$16.51

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Zeta Global is trading at $16.51, well below its DCF‑derived fair value of roughly $37.7, implying an upside of more than 70%. The stock’s 30‑day volatility sits above 50% and a computed beta of 2.78 signals pronounced price swings relative to the market. Technicals are mixed: the 20‑day SMA ($17.64) sits just above the current price, the MACD histogram is negative and the RSI at 42 points to a neutral‑to‑slightly‑oversold condition. Nonetheless, the price remains above the identified support at $15.94 and well below the resistance near $19.88, offering a modest downside cushion. Volume has been increasing, suggesting growing investor interest despite the heightened risk profile.
On the fundamentals side, management raised its 2026 revenue outlook to $1.785 billion and projects free cash flow of $235 million, a notable improvement over prior guidance. Forward EPS of $1.20 contrasts sharply with the trailing loss of $0.10, indicating a potential earnings turnaround. The company’s gross margin of 60% and positive free cash flow generation further support the upside thesis. Analyst consensus is strongly positive, with 13 analysts averaging a “strong buy” rating and a median price target of $30. The business operates in the high‑growth software‑infrastructure niche, leveraging AI‑driven platforms such as Athena and its CDP+, which could fuel long‑term expansion. However, the lack of a dividend and a current negative operating margin keep cash flow risk in view. Taken together, the sizable valuation gap, aggressive growth guidance, and strong analyst endorsement outweigh the short‑term technical headwinds, making Zeta Global an attractive speculative play.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near support with limited downside
  • bearish MACD histogram
  • high volatility and beta

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • raised 2026 revenue and free cash flow guidance
  • DCF upside >70%
  • strong analyst consensus

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • AI‑driven Athena platform scaling
  • large valuation gap to fair value
  • industry positioning in high‑growth software infrastructure

Key Metrics & Analysis

Financial Health

Revenue Growth49.90%
Profit Margin-1.61%
P/E Ratio13.8
ROE-2.97%
ROA1.55%
Debt/Equity24.83
P/B Ratio5.0
Op. Cash Flow$213.8M
Free Cash Flow$254.8M
Industry P/E39.0

Technical Analysis

TrendNeutral
RSI42.6
Support$15.94
Resistance$19.88
MA 20$17.64
MA 50$17.19
MA 200$18.47
MACDBearish
VolumeIncreasing
Fear & Greed Index87.98

Valuation

Fair Value$37.73
Target Price$28.77
Upside/Downside74.25%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta2.78
Volatility52.27%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.